Intravitreal methotrexate in therapeutically resistant exudative age-related macular degeneration.
Kurup
Shree K
SK
Gee
Chris
C
Greven
Craig M
CM
D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D004351:Drug Resistance; D005122:Exudates and Transudates; D005451:Fluorescein Angiography; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007267:Injections; D008268:Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D011379:Prognosis; D041623:Tomography, Optical Coherence; D014792:Visual Acuity; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D007166:Immunosuppressive Agents; D008727:Methotrexate